Permanent Gene Correction By Means Of Nucleotide-Modified Messenger Rna - EP3054993

The patent EP3054993 was granted to Eberhard Karls Universitt Tbingen Medizinische Fakultt on Dec 4, 2019. The application was originally filed on Oct 6, 2014 under application number EP14781175A. The patent is currently recorded with a legal status of "Revoked".

EP3054993

EBERHARD KARLS UNIVERSITT TBINGEN MEDIZINISCHE FAKULTT
Application Number
EP14781175A
Filing Date
Oct 6, 2014
Status
Revoked
Jan 14, 2022
Grant Date
Dec 4, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBBSep 3, 2020WICHMANNADMISSIBLE

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2013117870
DESCRIPTIONWO2011012316
INTERNATIONAL-SEARCH-REPORTUS2013117870
INTERNATIONAL-SEARCH-REPORTWO2007024708
OPPOSITIONDE102013111099
OPPOSITIONUS2012195936
OPPOSITIONUS2013117870
OPPOSITIONWO2013063315
OPPOSITIONWO2014186585
OPPOSITIONWO2015052133

Non-Patent Literature (NPL) Citations (49) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- CARLSON ET AL., "Targeting DNA with fingers and TALENs", MOLECULAR THERAPY-NUCLEIC ACIDS, (2012), vol. 1, page E3-
DESCRIPTION- DOYON, Y. ET AL., NAT BIOTECHNOL, (2008), vol. 26, pages 702 - 708-
DESCRIPTION- KARIK6, "Increased Erythropoiesis in Mice Injected With Submicrogram Quantities of Pseudouridine-containing mRNA Encoding Erythropoietin", MOLECULAR THERAPY, (2012), vol. 16, no. 11, pages 1833 - 1844-
DESCRIPTION- KORMANN ET AL., "Expression of therapeutic proteins after delivery of chemically modified mRNA in mice", LETTERS TO NATURE BIOTECHNOLOGY, (2011), pages 1 - 6-
DESCRIPTION- MAIL ET AL., "RNA-guided human genome engineering via Cas9", SCIENCE, (2013), vol. 339, no. 6121, pages 823 - 826-
DESCRIPTION- NAFEE, N.; TAETZ, S.; SCHNEIDER, M.; SCHAEFER, U.F.; LEHR, C.M., NANOMEDICINE, (2007), vol. 3, pages 173 - 183-
DESCRIPTION- TSAI ET AL., "Dimeric CRISPR RNA-guided Fokl nucleases for highly specific genome editing", NATURE BIOTECHNOLOGY, (2014), vol. 32, pages 569 - 576, XP055378307-
DESCRIPTION- URNOV, F.D. ET AL., NATURE, (2005), vol. 435, pages 646 - 651-
DESCRIPTION- YOUNG C. ET AL., NAT PROT, (2014), vol. 9, pages 1900 - 1915-
DESCRIPTION- CONG ET AL., "Multiplex genome engineering using CRISPR/Cas systems", SCIENCE, (2013), vol. 339, no. 6121, doi:doi:10.1126/science.1231143, pages 819 - 823, XP055469277
INTERNATIONAL-SEARCH-REPORT- A Mccaffrey, "The Buzz on the Cut: From Dream to Reality", (20130701), pages 1 - 15, URL: http://zon.trilinkbiotech.com/2013/07/01/the-buzz-on-the-cut-from-dream-to-reality/, (20141218), XP055159475 [XD] 1,2,4,5,12,15 * the whole document * [Y] 3,6-11,13,14-
INTERNATIONAL-SEARCH-REPORT- "Biotechnology / Life Sciences in Baden-Württemberg Gene therapies for pulmonary disease are close to final development", (20140915), URL: http://www.bio-pro.de/magazin/index.html?lang=en&artikelid=/artikel/10062/index.html, (20141219), XP055159736 [XP] 1-15 * the whole document *-
INTERNATIONAL-SEARCH-REPORT- YAMAMOTO A ET AL, "Current prospects for mRNA gene delivery", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, vol. 71, no. 3, doi:10.1016/J.EJPB.2008.09.016, ISSN 0939-6411, (20090301), pages 484 - 489, (20081010), XP025992169 [A] 1-15 * page 487, column l, paragraph 4 * * page 487, column r, line 41 - page 488, column l, line 2 *
INTERNATIONAL-SEARCH-REPORT- MORGAN L. MAEDER ET AL, "Supplemental data: to : Rapid "Open-Source" Engineering of Customized Zinc-Finger Nucleases for Highly Efficient Gene Modification", MOLECULAR CELL, (20080701), vol. 31, no. 2, doi:10.1016/j.molcel.2008.06.016, ISSN 1097-2765, pages 294 - 301, XP055143755 [A] 3,14 * abstract *
INTERNATIONAL-SEARCH-REPORT- GERALD SCHWANK ET AL, "Functional Repair of CFTR by CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients", CELL STEM CELL, (20131201), vol. 13, no. 6, doi:10.1016/j.stem.2013.11.002, ISSN 1934-5909, pages 653 - 658, XP055102691 [AP] 3,14 * the whole document *
INTERNATIONAL-SEARCH-REPORT- GAJ THOMAS ET AL, "ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering", TRENDS IN BIOTECHNOLOGY, (20130509), vol. 31, no. 7, doi:10.1016/J.TIBTECH.2013.04.004, ISSN 0167-7799, pages 397 - 405, XP028571313 [A] 1-15 * page 401, column l, paragraph 1 - column r, paragraph 1 * * page 402, column l, paragraph 1 - paragraph 3 *
INTERNATIONAL-SEARCH-REPORT- R SCOTT MCIVOR, "Therapeutic Delivery of mRNA: The Medium Is the Message", MOLECULAR THERAPY, (20110501), vol. 19, no. 5, doi:10.1038/mt.2011.67, ISSN 1525-0016, pages 822 - 823, XP055159404 [I] 1,2,12,15 * page 822, column r, paragraph 2 * * page 823, column m, line 8 - line 14 *
INTERNATIONAL-SEARCH-REPORT- MICHAEL S D KORMANN ET AL, "Expression of therapeutic proteins after delivery of chemically modified mRNA in mice", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, UNITED STATES, vol. 29, no. 2, doi:10.1038/NBT.1733, ISSN 1546-1696, (20110201), pages 154 - 157, (20110109), XP002696192 [AD] 1-15 * abstract * * figures 1,2,3 *
INTERNATIONAL-SEARCH-REPORT- UGUR SAHIN ET AL, "mRNA-based therapeutics - developing a new class of drugs", NATURE REVIEWS DRUG DISCOVERY, (20140919), vol. 13, no. 10, doi:10.1038/nrd4278, ISSN 1474-1776, pages 759 - 780, XP055159205 [T] * abstract *
INTERNATIONAL-SEARCH-REPORT- FYODOR D URNOV ET AL, "Genome editing with engineered zinc finger nucleases", NATURE REVIEWS, (20100901), vol. 11, no. 9, doi:10.1038/NRG2842, ISSN 1471-0064, pages 636 - 646, XP008150557 [Y] 3,14 * the whole document * * table 1 *
OPPOSITION- Burgess Rob, "Types of Nanoparticle-based systems for drug delivery", Understanding Nanomedicine - An Introductory Textbook, (20120101), pages 267 - 270, XP055959371-
OPPOSITION- Mccaffrey, "The Buzz on the Cut: From Dream to Reality | TriLink BioTechnologies", TriLink biotechnologies, (20130701), pages 1 - 21, TriLink biotechnologies, URL: https://www.trilinkbiotech.com/blog/the-buzz-on-the-cut-from-dream-to-reality/, (20220909), XP055959373-
OPPOSITION- Pryhuber Gloria S, "MINIREVIEW Regulation and Function of Pulmonary Surfactant Protein B", MOLECULAR GENETICS AND METABOLISM, (19980331), pages 217 - 228, MOLECULAR GENETICS AND METABOLISM, URL: https://reader.elsevier.com/reader/sd/pii/S1096719298927226?token=B53907D6826CD109AC53310A7B365870AF635FFB17A207B0314C93014F21A002FBF493EC923F4E140CCA264D45DC6902&originRegion=eu-west-1&originCreation=20220909105006, (20220909), XP055959392-
OPPOSITION- Cerchia Laura; Giangrande Paloma H; McNamara James O; de Franciscis Vittorio, "Cell-Specific Aptamers for Targeted Therapies", Cerchia Laura; Giangrande Paloma H; McNamara James O; de Franciscis Vittorio, Mayer, Günter, Nucleic Acid and Peptide Aptamers : Methods and Protocols, US , New York : Humana Pr., 2009 , vol. 535, pages 59 - 78, doi:10.1007/978-1-59745-557-2_5, ISBN 978-1-934115-89-3, XP008178604
OPPOSITION- Dallas A., Vlassov A. V., Kazakov S. A., "Principles of Nucleic Acid Cleavage by Metal Ions", NUCLEIC ACIDS AND MOLECULAR BIOLOGY., DE , SPRINGER VERLAG, BERLIN. , (20040101), vol. 13, pages 61 - 88, doi:10.1007/978-3-642-18510-6_6, ISSN 0933-1891, XP055959398
OPPOSITION- Karikó K, Buckstein M, Ni H, Weissman D, "Suppression of RNA recognition by Toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA", Immunity, Cell Press, AMSTERDAM, NL, AMSTERDAM, NL , (20050801), vol. 23, no. 2, doi:10.1016/J.IMMUNI.2005.06.008, ISSN 1074-7613, pages 165 - 175, XP002634064
OPPOSITION- Phua Kyle K.L.; Leong Kam W.; Nair Smita K., "Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format", Journal of Controlled Release, Elsevier, AMSTERDAM, NL, AMSTERDAM, NL , (20130107), vol. 166, no. 3, doi:10.1016/j.jconrel.2012.12.029, ISSN 0168-3659, pages 227 - 233, XP028994982
OPPOSITION- Nafee, N. Taetz, S. Schneider, M. Schaefer, U.F. Lehr, C.M., "Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides", Nanomedicine: Nanotechnology, Biology, and Medicine, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20070829), vol. 3, no. 3, doi:10.1016/j.nano.2007.03.006, ISSN 1549-9634, pages 173 - 183, XP022219203
OPPOSITION- Jin S., Ye K., "Nanoparticle-Mediated Drug Delivery and Gene Therapy", Biotechnology Progress, American Chemical Society, (20070202), vol. 23, no. 1, doi:10.1021/bp060348j, ISSN 8756-7938, pages 32 - 41, XP055959377
OPPOSITION- Xingfang Su, Jennifer Fricke, Daniel G. Kavanagh, Darrell J. Irvine, "In Vitro and in Vivo mRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles", Molecular Pharmaceutics, American Chemical Society, (20110606), vol. 8, no. 3, doi:10.1021/mp100390w, ISSN 15438384, pages 774 - 787, XP055127583
OPPOSITION- D Carroll, "Progress and prospects: Zinc-finger nucleases as gene therapy agents", Gene Therapy, Macmillan Press Ltd., (20081101), vol. 15, no. 22, doi:10.1038/gt.2008.145, ISSN 09697128, pages 1463 - 1468, XP055041104
OPPOSITION- KARIKÓ KATALIN ET AL, "Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.", Molecular Therapy, Nature Publishing Group, GB, GB , (20081101), vol. 16, no. 11, doi:10.1038/mt.2008.200, ISSN 1525-0024, pages 1833 - 1840, XP002598556
OPPOSITION- MCIVOR R SCOTT, "Therapeutic Delivery of mRNA: The Medium Is the Message", Molecular Therapy, Elsevier Inc., US, US , (20110502), vol. 19, no. 5, doi:10.1038/mt.2011.67, ISSN 1525-0016, pages 822 - 823, XP002758393
OPPOSITION- Wang Yuhua; Su Hsing-Hao; Yang Yang; Hu Yunxia; Zhang Lu; Blancafort Pilar; Huang Leaf, "Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy.", Molecular Therapy, Nature Publishing Group, GB, GB , (20130201), vol. 21, no. 2, doi:10.1038/mt.2012.250, ISSN 1525-0024, pages 358 - 367, XP009170717
OPPOSITION- Karikó K, Muramatsu H, Keller J M, Weissman D., "Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin.", Molecular Therapy, Nature Publishing Group, GB, GB , (20120501), vol. 20, no. 5, doi:10.1038/mt.2012.7, ISSN 1525-0024, pages 948 - 953, XP002696191
OPPOSITION- Zhang Yuan, Satterlee Andrew, Huang Leaf, "In Vivo Gene Delivery by Nonviral Vectors: Overcoming Hurdles?", Molecular Therapy, Elsevier Inc., US, US , (20120701), vol. 20, no. 7, doi:10.1038/mt.2012.79, ISSN 1525-0016, pages 1298 - 1304, XP055959381
OPPOSITION- URNOV F D ET AL, "Highly efficient endogenous human gene correction using designed zinc-finger nucleases.", Nature, Nature Publishing Group UK, London, London, (20050602), vol. 435, no. 7042, doi:10.1038/nature03556, ISSN 0028-0836, pages 646 - 651, XP002411069
OPPOSITION- Michael S D Kormann et al, "Expression of therapeutic proteins after delivery of chemically modified mRNA in mice", Nature Biotechnology, Gale Group Inc., (20110201), vol. 29, no. 2, doi:10.1038/nbt.1733, ISSN 10870156, pages 154 - 157, XP055040839
OPPOSITION- Shengdar Q Tsai et al, "Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing", Nature Biotechnology, Gale Group Inc., vol. 32, no. 6, doi:10.1038/nbt.2908, ISSN 10870156, pages 569 - 576, XP055178523
OPPOSITION- J. Keith Joung, Sander Jeffry D., "TALENs: a widely applicable technology for targeted genome editing", Nature Reviews Molecular Cell Biology, Nature Publishing Group UK, London, London, vol. 14, no. 1, doi:10.1038/nrm3486, ISSN 1471-0072, pages 49 - 55, XP055282847
OPPOSITION- Andrew J. Geal et al, "Nonviral delivery of self-amplifying RNA vaccines.", Proceedings of the National Academy of Sciences, National Academy of Sciences, (20120904), vol. 109, no. 36, doi:10.1073/PNAS.1209367109, ISSN 0027-8424, pages 14604 - 14609, XP002683929
OPPOSITION- Daniel F. Carlson, Wenfang Tan, Simon G. Lillico, Dana Stverakova, Chris Proudfoot, Michelle Christian, Daniel F. Voytas, Charles R. Long, C. Bruce A. Whitelaw, and Scott C. Fahrenkrug, "Efficient TALEN-mediated gene knockout in livestock", Proceedings of the National Academy of Sciences, National Academy of Sciences, (20121001), vol. 109, no. 43, doi:10.1073/pnas.1211446109 , ISSN 0027-8424, pages 17382 - 17387, XP002716843
OPPOSITION- Rogers D F, Laurent G J, "New ideas on the pathophysiology and treatment of lung disease", Thorax, BMJ Publishing Group, GB, GB , (19980301), vol. 53, no. 3, doi:10.1136/thx.53.3.200, ISSN 0040-6376, pages 200 - 203, XP055959388
OPPOSITION- Martino Sabata, Di Girolamo Ilaria, Tiribuzi Roberto, D'angelo Francesco, Datti Alessandro, Orlacchio Aldo, "Efficient siRNA Delivery by the Cationic Liposome DOTAP in Human Hematopoietic Stem Cells Differentiating into Dendritic Cells", Journal of Biomedicine and Biotechnology, (20090101), vol. 2009, doi:10.1155/2009/410260, ISSN 1110-7243, pages 1 - 7, XP055959394
OPPOSITION- Sivaprakash Ramalingam, Annaluru Narayana, Chandrasegaran Srinivasan, "A CRISPR way to engineer the human genome", Genome Biology, BioMed Central Ltd., (20130101), vol. 14, no. 2, doi:10.1186/gb-2013-14-2-107, ISSN 1465-6906, pages 1 - 4, XP055323697
OPPOSITION- Fansheng Kong, Zhou, Ge, Liu, Wang, "Mannosylated liposomes for targeted gene delivery", International Journal of Nanomedicine, doi:10.2147/IJN.S29183, page 1079, XP055321563
OPPOSITION- Kenneth C Mccullough,et al, "Functional RNA delivery targeted to dendritic cells by synthetic nanoparticles", Therapeutic Delivery, Future Science Ltd., GB, GB , (20120901), vol. 3, no. 9, doi:10.4155/tde.12.90, ISSN 2041-5990, pages 1077 - 1099, XP055524291
OPPOSITION- Phua Kyle, "In vivo transfection efficiencies and pharmacokinetics of mRNA delivered in naked and nanoparticle format", Journal of Genetic Syndromes & Gene Therapy, doi:10.4172/2157-7412.S1.005, (20121101), pages 1 - 1, Journal of Genetic Syndromes & Gene Therapy, URL: https://www.longdom.org/conference-abstracts-files/2157-7412-S1.005-005.pdf, (20220909), XP055959385
OPPOSITION- Alicia Rodriguez, Ana Del, Maria Angeles, "Non-Viral Delivery Systems in Gene Therapy", Gene Therapy - Tools and Potential Applications, InTech , (20130227), doi:10.5772/52704, ISBN 978-953-51-1014-9, XP055318222

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents